Japan's much-maligned Covid-19 vaccine campaign quietly gathers speed

Japan has faced criticism for the pace of its inoculation drive

Japan vaccination
Bloomberg
1 min read Last Updated : Jun 02 2021 | 11:22 PM IST
After some false starts, Japan’s much-delayed vaccine rollout is quietly picking up steam.
 
The seven-day average of doses has quadrupled in just two weeks, with about a quarter of the nearly 14 million shots given coming in the past week alone. A flurry of initiatives are being implemented or floated to further ramp up the drive — among them an expansion of those qualified to administer the shots as well as mass vaccination at workplaces and in “night-time entertainment” districts.
 
Japan has faced criticism for the pace of its inoculation drive, which on paper began in February but struggled to get off the ground until last month. Facing initial uncertainties over supplies, shortages of medical personnel, and burdened by a decentralised medical system, it seemed as if the campaign would take years.
 
Although the percentage of Japan’s total population that has received at least one dose of vaccine — 7.8% — still lags other developed countries, some critics of the nation’s inoculation effort say things are going better than they might have thought.   


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :JapanCoronavirus VaccineVaccination

Next Story